ACE and COVID-19: Another meta-analysis covering the studies on ACE gene I/D polymorphism and severity of SARS-CoV-2 infection in hospitalized patients by Oscanoa et al. reported that patients with the dominant homozygous DD genotype were at 47% higher risk of severe COVID-19 as compared to the mutant II genotype [22].